Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Multiple Sclerosis

Free Subscription 03.11.2025 1 Ann Neurol 1 BMC Neurol 1 J Immunol 1 J Neurol 1 J Neurol Neurosurg Psychiatry 4 Mult Scler 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. KUNCHOK A, Amin M, Ongphichetmetha T, Du M, et al
   Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability Associations.
   Ann Neurol. 2025 Jul 29. doi: 10.1002/ana.27309.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. WILSON S, Leray E, Calocer F, Rollot F, et al
   Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France.
   BMC Neurol. 2025;25:441.
   PubMed         Abstract available
   
   

   
   J Immunol

3. CHURCH ME, Hernandez SI, Alvarez JI
   Neuroinflammatory canine disorders: unveiling disease mechanisms from a One Health perspective.
   J Immunol. 2025;214:2535-2542.
   PubMed         Abstract available
   
   

   
   J Neurol

4. MONTE G, Tiralongo G, Papetti L, Ferilli MAN, et al
   Complete Epstein-Barr virus seropositivity in a cohort of pediatric onset multiple sclerosis: a comparison to other autoimmune diseases.
   J Neurol. 2025;272:735.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

5. FOONG YC, Merlo D, Gresle M, Buzzard K, et al
   Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2025 Oct 29:jnnp-2025-336513.
   PubMed         Abstract available
   
   

   
   Mult Scler

6. ZIEMSSEN T, Freedman MS, Bar-Or A, Montalban X, et al
   Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis.
   Mult Scler. 2025 Oct 29:13524585251389797. doi: 10.1177/13524585251389797.
   PubMed         Abstract available
   
   
7. BANKS SA, Baker MR, Flanagan EP, Permezel FE, et al
   Tremor and disability outcomes following deep brain stimulation for multiple sclerosis-associated tremor.
   Mult Scler. 2025 Oct 27:13524585251387935. doi: 10.1177/13524585251387935.
   PubMed         Abstract available
   
   
8. BRIGGS FB, Yang J, Toljan K, Conway DS, et al
   Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factors.
   Mult Scler. 2025 Oct 26:13524585251384060. doi: 10.1177/13524585251384060.
   PubMed         Abstract available
   
   
9. CHERTCOFF AS, Ruiz-Alguero M, Yusuf F, Zhao Y, et al
   Psychiatric morbidity during the multiple sclerosis prodrome is associated with future disability.
   Mult Scler. 2025 Oct 26:13524585251382801. doi: 10.1177/13524585251382801.
   PubMed         Abstract available
   
   

   
   PLoS One

10. LTEIF MR, Kalot J, Jaouni ME, Khoury SJ, et al
    E-health literacy levels of multiple sclerosis patients in Lebanon.
    PLoS One. 2025;20:e0335084.
    PubMed         Abstract available
    
    
11. JIANG L, Jin Y, Han Y, Fu J, et al
    TRIM37-mediated stabilization of PEX5 via monoubiquitination attenuates oxidative stress and demyelination in multiple sclerosis insights from EAE and LPC-induced experimental models.
    PLoS One. 2025;20:e0335198.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.